|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/28 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/04 |
| (11) | Patento numeris | 3489261 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18194705.2 |
| Europos patento paraiškos padavimo data | 2013-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261693230 P | 2012-08-24 | US | |
| 201261709055 P | 2012-10-02 | US | |
| 201261709803 P | 2012-10-04 | US |
| (72) |
KIPPS, Thomas, James, US
YU, Jian, US
CUI, Bing, US
CHEN, Liguang, US
WIDHOPF, George, US
PRUSSAK, Charles, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS |
| ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS |